Caricamento...
A gonadotropin-releasing hormone antagonist reduces serum adrenal androgen levels in prostate cancer patients
BACKGROUND: Adrenal androgens play an important role in the development of castration-resistant prostate cancer therapeutics. The effect of gonadotropin-releasing hormone (GnRH) antagonists on adrenal androgens has not been studied sufficiently. We measured testicular and adrenal androgen levels in...
Salvato in:
| Pubblicato in: | BMC Urol |
|---|---|
| Autori principali: | , , , , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
BioMed Central
2017
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5575925/ https://ncbi.nlm.nih.gov/pubmed/28851333 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12894-017-0261-z |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|